Retraction
β-Elemene Improves Morphine Tolerance in Bone Cancer Pain via N-Methyl-D-Aspartate Receptor 2B Subunit-Mediated μ-Opioid Receptor
Paper Information
Record ID:
60682
Author(s):
Publication Date:
September 17, 2022
Retraction Date:
November 29, 2023
(2.0 year years ago)
Subjects:
Institutions:
- Department of Rare and Head and Neck Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China
- Rehabilitation Department, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations0
Post-Retraction3
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
The complementary and alternative roles of elemene injection in cancer: An umbrella review
Jixin Chen, Shuqi Chen, Huiyan Luo et al. (6 authors)
Pharmacological Research
Open Access
Published: Nov 2023
10 citations
10 citations
9 days before retraction
Endogenous opiates and behavior: 2022
Richard J. Bodnar
Peptides
Published: Sep 2023
13 citations
13 citations
78 days before retraction
Retracted: <i>β</i>‐Elemene Improves Morphine Tolerance in Bone Cancer Pain via N‐Methyl‐D‐Aspartate Receptor 2B Subunit‐Mediated <i>μ</i>‐Opioid Receptor
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
332 days before retraction
Quick Stats
Total Citations:
8
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025